Similar articles

• [Treatment of hypertension with the alpha- and beta-adrenergic blockader trandat].

  Erina EV, Charyev KhE, Lediashova GA, Smolenskiĭ AV. Erina EV, et al. Ter Arkh. 1983;55(9):43-8. Ter Arkh. 1983. PMID: 6314576 Russian. No abstract available.
• Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.

  Zschiedrich H, Neurohr W, Lüth JB, Philipp T, Distler A. Zschiedrich H, et al. Klin Wochenschr. 1983 Jul 1;61(13):661-7. doi: 10.1007/BF01487583. Klin Wochenschr. 1983. PMID: 6310204
• [Interaction of labetalol with alpha- and beta-adrenergic receptors : biochemical study (author's transl)].

  Dausse JP, Guicheney P, Maich PJ, Meyer P. Dausse JP, et al. Nouv Presse Med. 1978 Oct 14;7(35):3121-3. Nouv Presse Med. 1978. PMID: 31601 French.
• The pharmacological basis for the use of labetalol in the treatment of hypertension.

  Prichard BN, Richards DA. Prichard BN, et al. J Cardiovasc Pharmacol. 1981;3 Suppl 1:S24-9. doi: 10.1097/00005344-198100031-00003. J Cardiovasc Pharmacol. 1981. PMID: 6169957 Review. No abstract available.
• Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects.

  MacCarthy EP, Bloomfield SS. MacCarthy EP, et al. Pharmacotherapy. 1983 Jul-Aug;3(4):193-219. doi: 10.1002/j.1875-9114.1983.tb03252.x. Pharmacotherapy. 1983. PMID: 6310529 Review.